The global epigenetics market is projected to reach the value of $18.2 billion by the year 2015 driven by investigation of factors influencing cellular malfunction and disease development.
Epigenetics is a rapidly growing field of the biological science industry and biological researchers are progressively attempting to discover the process of cells exploiting the information programmed in genomes. It is the study of regulation of mechanisms other than DNA sequence over the genomic information programmed in DNA sequence. Recent discoveries and developments in this field are expected to bring about major revolution in healthcare industry and treatment of diseases in the long term.
Although cancer is regarded as mutational disease, it is a major area for epigenetic diagnostics and therapeutics. Most of the attention in epigenetic research is focused on DNA methylation and advancements in this technology are driving the growth of this industry.
Stem cells also represent a growing area in the field of epigenetics. Epigenetic alterations regulating cell development are enabling researchers to determine the type of tissues a stem cell turns into.
- Bisulfite Conversion Kits
- Chromatin Immunoprecipitation
The epigenetics market research report analyzes this market depending on its segments and major geographies. Geographies analyzed under this research report are North America, Asia Pacific, Europe, and Rest of the World.
This report includes comprehensive analysis of current trends in the market, industry growth drivers, factors affecting market growth, market structure, and industry projections for upcoming years. This report also includes detailed analysis of technological improvements in the field, Porter’s five force model analysis, and complete company profiles of top industry players. The report provides review of micro and macro factors significant with respect to new entrants and existing market players with value chain analysis.
Some of the major players dominating this market are 454 Life Sciences, Abcam plc, Active Motif Inc., Affymetrix Inc., Agilent Technologies Inc., AVIVA Systems Biology, Epigenomics AG, GATC Biotech AG, GeneGo Inc., Human Genetic Signatures Pty. Ltd., Illumina Inc., Millipore, Orion Genomics LLC, Qiagen N.V., Regulus Therapeutics LLC, Roche Nimblegen, Rubicon Genomics Inc., Sigma-Aldrich Co., Zymo Research Corp., and others.
Request for Enquiry @ https://www.marketresearchreports.biz/sample/enquiry/138709
Reasons for Buying this Report
- The report provides technological growth map over time and explains its impact on market
- It provides clear understanding of changing competitive dynamics and keeps you ahead of competitors
- This research report provides overview of major market forces driving and restraining market growth
- It helps in making informed business decisions by making in-depth analysis of market
- It provides distinctive graphics and exemplified SWOT analysis of major industry segments
- It also provides up-to-date analysis of latest trends in market and helps you stay updated with recent technological improvements
- The report provides detailed analysis of major competitors and their strategies
Check Discount @ https://www.marketresearchreports.biz/sample/checkdiscount/138709
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207